AwesomeCapital
Sunday, December 7, 2025
Regeneron Lynozyfic monotherapy in newly diagnosed multiple myeloma impressive responses
›
All three dose groups (50 mg, 100 mg and 200 mg) showed impressive monotherapy efficacy, with VGPR+ (very good partial response or better)...
Telix Advances Prostate Cancer Therapy with Phase 3 Trial Expansion
›
Telix Pharmaceuticals has announced the dosing of the first patient in Part 2 of its ProstACT Global Phase 3 study, which evaluates the pr...
European CEOs downbeat on Europe, favour US investment, survey shows
›
Chief executives of large European companies are downbeat on Europe's economic prospects, albeit less so than six months ago, and have...
Russia Stands "Shoulder To Shoulder" With Venezuela, Blasts US War Footing
›
Russia on Sunday issued new statements voicing deep concern over the US force posture in the southern Caribbean, warning against any possi...
https://nypost.com/2025/12/07/us-news/trump-admin-has-rescued-62k-migrant-kids-from-sex-trafficking-child-labor-border-czar-homan-says/
›
https://nypost.com/2025/12/07/us-news/ilhan-omar-compares-stephen-miller-to-nazis-in-germany/
›
https://nypost.com/2025/12/07/us-news/zohran-mamdani-gives-advice-to-thwart-evade-ice-in-video-message-calling-to-stand-up-to-feds/
›
‹
›
Home
View web version